Schrodinger, Inc. (SDGR) income statement
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3053% above fair value
$26.34−0.86 (-3.16%)
Close on Nov 19, 2026Market cap $1.97BP/E –Yield –
Schrodinger, Inc. financial ratios
See a number that looks wrong?